论文信息 - A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer - 字舞流文

A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer

K. Hirata | R. Takimoto | T. Furuhata | Minoru Takahashi | J. Kato | M. Kobune | Y. Okagawa | T. Mizuguchi | Tsuyoshi Hayashi | K. Takada | K. Murase | S. Iyama | Tsutomu Sato | K. Miyanishi | Y. Kawano | K. Okita | H. Ohnuma | M. Hirakawa | T. Osuga | Y. Sato